Vasodilator effects of the endothelin ET(A) receptor selective antagonist BMS-193884 in healthy men

AIMS: A number of endothelin receptor antagonists (ERAs) are currently in clinical development as potential therapies in states characterized by vasoconstriction, such as systemic hypertension. We investigated the haemodynamic effects of locally and systemically active doses of BMS-193884, an endoth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dhaun, Neeraj, Strachan, Fiona E, Newby, David E, Johnston, Neil R, Ford, Neville F, Hammett, Janis L, Palmisano, Maria, Webb, David J
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2005
Assuntos:
Pharmacokinetics and Pharmacodynamics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884878/
https://ncbi.nlm.nih.gov/pubmed/16305585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2005.02503.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados